Innate Pharma SA Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities
Innate Pharma SA (IPHYF) reported Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities of -EUR 616.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities · last filed 2026-04-01
| Period end | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 6 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 12 month |
|---|---|---|
| 2025-12-31 | -616.00K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -250.00K EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | -7.04M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | -3.57M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | -4.00M EUR 20-F · filed 2025-04-30 | |
| 2023-06-30 | -3.46M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | -23.43M EUR 20-F · filed 2024-04-04 | |
| 2022-06-30 | -20.49M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | -6.06M EUR 20-F · filed 2023-04-06 | |
| 2021-06-30 | -5.91M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | -45.14M EUR 20-F · filed 2022-04-04 |